Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by 3d Transcranial Ultrasound Brain Imaging

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Active Not Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT06780436Active Not Recruiting

3D Transcranial Ultrasound Brain Imaging (3D-TRUBI) Instrument for Point-of-Care Diagnosis of Intracranial Hemorrhages

NCT06178250Not ApplicableCompleted

Placenta, Fetal Liver, Sectional Ductus Venosus Volumes Examined by Three-dimensional Ultrasound in the Second Trimester

Showing all 2 trials

Research Network

Common Treatments

  • 3d Transcranial Ultrasound Brain Imaging1
  • 3d Sonography1

Active Sponsors

  • Uniformed Services University of the Health Sciences1
  • Brooke Army Medical Center1
  • Sanliurfa Mehmet Akif Inan Education and Research Hospital1
  • The Geneva Foundation1

Related Conditions

  • Intracranial Hemorrhages1
  • Traumatic Brain Hemorrhage1
  • Ultrasound Exams1
  • Fetal Liver Volume1
  • Gestational Diabetes1

Activity Timeline